V
Vivozon Pharmaceutical Co Ltd
KOSDAQ:082800
Vivozon Pharmaceutical Co Ltd
KOSDAQ:082800
Price:
4 180
KRW
4.37%
Market Closed
Market Cap:
₩253.8B
Balance Sheet
Balance Sheet Decomposition
Vivozon Pharmaceutical Co Ltd
Vivozon Pharmaceutical Co Ltd
Balance Sheet Decomposition is not available for
Vivozon Pharmaceutical Co Ltd
Vivozon Pharmaceutical Co Ltd
Balance Sheet
Vivozon Pharmaceutical Co Ltd
Vivozon Pharmaceutical Co Ltd
Currency: KRW
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||
| Cash & Cash Equivalents |
709
|
1 442
|
1 553
|
5 127
|
1 033
|
1 113
|
846
|
16 206
|
6 847
|
7 676
|
7 780
|
1 035
|
1 212
|
1 689
|
1 598
|
12 317
|
57 331
|
64 331
|
13 799
|
2 351
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
2
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Cash Equivalents |
709
|
1 442
|
1 553
|
5 127
|
1 033
|
1 113
|
846
|
16 206
|
6 847
|
7 676
|
7 775
|
1 033
|
1 212
|
1 689
|
1 598
|
12 317
|
57 330
|
64 330
|
13 799
|
2 351
|
|
| Short-Term Investments |
500
|
600
|
1 000
|
6 250
|
1 013
|
2 034
|
22
|
54
|
540
|
609
|
717
|
0
|
2 043
|
120
|
120
|
20 260
|
12 267
|
26 346
|
40 456
|
12 448
|
|
| Total Receivables |
138
|
1 296
|
4 265
|
2 187
|
1 983
|
6 981
|
7 364
|
8 436
|
16 076
|
13 017
|
19 115
|
12 917
|
12 977
|
13 191
|
12 921
|
9 025
|
6 362
|
11 683
|
13 448
|
9 788
|
|
| Accounts Receivables |
138
|
997
|
4 210
|
2 176
|
1 904
|
6 852
|
7 212
|
8 091
|
15 392
|
11 378
|
18 115
|
8 716
|
12 969
|
13 163
|
12 920
|
8 991
|
4 535
|
10 827
|
11 482
|
9 038
|
|
| Other Receivables |
0
|
299
|
55
|
11
|
79
|
129
|
152
|
345
|
684
|
1 639
|
1 000
|
4 201
|
8
|
28
|
1
|
34
|
1 827
|
856
|
1 966
|
750
|
|
| Inventory |
134
|
1 079
|
1 903
|
3 708
|
3 493
|
6 837
|
10 683
|
9 319
|
19 186
|
26 773
|
27 291
|
20 134
|
16 763
|
15 108
|
12 944
|
7 786
|
2 680
|
12 927
|
15 890
|
11 199
|
|
| Other Current Assets |
1
|
93
|
38
|
540
|
745
|
975
|
1 126
|
419
|
1 822
|
1 001
|
2 042
|
2 950
|
509
|
477
|
367
|
673
|
66 873
|
7 117
|
12 741
|
11 775
|
|
| Total Current Assets |
1 483
|
4 510
|
8 759
|
17 812
|
8 267
|
17 941
|
20 041
|
34 434
|
44 471
|
49 076
|
56 945
|
37 036
|
33 504
|
30 585
|
27 950
|
50 061
|
145 512
|
122 404
|
96 333
|
47 562
|
|
| PP&E Net |
1 006
|
2 107
|
10 697
|
11 271
|
10 561
|
16 222
|
12 851
|
36 226
|
81 586
|
13 905
|
15 339
|
10 011
|
6 476
|
5 574
|
3 549
|
3 148
|
1 314
|
25 228
|
32 807
|
33 968
|
|
| PP&E Gross |
1 006
|
2 107
|
10 697
|
11 271
|
10 561
|
16 222
|
12 851
|
36 226
|
81 586
|
13 905
|
15 339
|
10 011
|
0
|
0
|
0
|
0
|
1 314
|
25 228
|
32 807
|
33 968
|
|
| Accumulated Depreciation |
36
|
362
|
1 392
|
3 263
|
5 461
|
8 286
|
11 953
|
29 062
|
38 917
|
29 468
|
33 895
|
36 533
|
0
|
0
|
0
|
0
|
892
|
17 932
|
17 591
|
17 929
|
|
| Intangible Assets |
13
|
0
|
141
|
650
|
818
|
115
|
130
|
2 299
|
3 962
|
626
|
2 532
|
4 546
|
4 244
|
3 083
|
2 346
|
588
|
186
|
27 426
|
11 493
|
9 011
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4 531
|
3 524
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19 341
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
124
|
21
|
418
|
404
|
255
|
786
|
1 609
|
49
|
2 118
|
3 896
|
286
|
|
| Long-Term Investments |
0
|
20
|
32
|
38
|
3 063
|
4 653
|
6 778
|
4 851
|
4 448
|
4 007
|
3 948
|
1 406
|
4 039
|
2 391
|
1 677
|
44 413
|
16 602
|
48 493
|
45 857
|
95 242
|
|
| Other Long-Term Assets |
40
|
113
|
208
|
401
|
2 017
|
1 750
|
1 401
|
4 348
|
2 229
|
21
|
118
|
121
|
40
|
72
|
97
|
833
|
990
|
3 149
|
4 085
|
1 006
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4 531
|
3 524
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19 341
|
0
|
0
|
|
| Total Assets |
2 541
N/A
|
6 749
+166%
|
19 837
+194%
|
30 172
+52%
|
24 726
-18%
|
40 681
+65%
|
41 201
+1%
|
86 689
+110%
|
140 220
+62%
|
67 758
-52%
|
78 904
+16%
|
53 537
-32%
|
48 707
-9%
|
41 960
-14%
|
36 405
-13%
|
100 652
+176%
|
164 654
+64%
|
248 159
+51%
|
194 471
-22%
|
187 074
-4%
|
|
| Liabilities | |||||||||||||||||||||
| Accounts Payable |
67
|
1 634
|
886
|
756
|
1 084
|
4 213
|
6 672
|
2 355
|
6 676
|
9 146
|
17 182
|
4 015
|
9 379
|
8 888
|
8 703
|
7 288
|
5 495
|
6 332
|
6 622
|
6 152
|
|
| Accrued Liabilities |
27
|
18
|
39
|
27
|
19
|
43
|
606
|
388
|
609
|
826
|
272
|
240
|
0
|
0
|
0
|
0
|
222
|
1 843
|
2 167
|
1 848
|
|
| Short-Term Debt |
0
|
0
|
1 358
|
1 041
|
2 068
|
4 907
|
15 297
|
4 090
|
14 724
|
7 992
|
7 280
|
7 280
|
7 400
|
3 000
|
8 000
|
0
|
0
|
13 420
|
20 580
|
18 600
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
593
|
588
|
629
|
6 434
|
4 015
|
9 999
|
6 412
|
3 774
|
10 833
|
1 500
|
3 556
|
3 333
|
2 342
|
0
|
41 759
|
79 025
|
48 891
|
38 792
|
|
| Other Current Liabilities |
10
|
444
|
2 418
|
1 416
|
584
|
1 248
|
1 573
|
4 076
|
5 735
|
2 586
|
4 404
|
2 562
|
295
|
357
|
885
|
593
|
6 916
|
10 950
|
10 763
|
12 425
|
|
| Total Current Liabilities |
105
|
2 096
|
5 294
|
3 828
|
4 384
|
16 845
|
28 164
|
20 908
|
34 156
|
24 324
|
39 971
|
15 596
|
20 630
|
15 578
|
19 930
|
7 881
|
54 391
|
111 570
|
89 023
|
77 817
|
|
| Long-Term Debt |
571
|
1 561
|
3 666
|
1 944
|
1 196
|
2 313
|
4 829
|
16 261
|
49 460
|
15 000
|
2 889
|
3 556
|
3 000
|
2 063
|
0
|
23 216
|
7
|
15 979
|
14 644
|
1 481
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5 596
|
1 823
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4 766
|
16 055
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3 757
|
1 422
|
0
|
|
| Other Liabilities |
0
|
0
|
1
|
40
|
33
|
76
|
72
|
286
|
455
|
583
|
654
|
487
|
424
|
1 577
|
375
|
1 109
|
1 259
|
3 455
|
2 439
|
1 939
|
|
| Total Liabilities |
676
N/A
|
3 657
+441%
|
8 961
+145%
|
5 811
-35%
|
5 613
-3%
|
19 234
+243%
|
33 065
+72%
|
42 221
+28%
|
100 125
+137%
|
39 907
-60%
|
43 514
+9%
|
19 638
-55%
|
24 053
+22%
|
19 218
-20%
|
20 305
+6%
|
32 206
+59%
|
55 657
+73%
|
140 356
+152%
|
109 350
-22%
|
81 237
-26%
|
|
| Equity | |||||||||||||||||||||
| Common Stock |
1 000
|
1 250
|
1 250
|
3 220
|
3 220
|
5 346
|
5 346
|
16 415
|
16 492
|
16 492
|
18 969
|
18 969
|
18 969
|
18 969
|
18 969
|
37 230
|
60 215
|
70 326
|
84 953
|
117 022
|
|
| Retained Earnings |
184
|
547
|
8 330
|
9 438
|
4 056
|
1 931
|
15 183
|
29 069
|
35 323
|
45 578
|
48 214
|
49 525
|
59 171
|
60 994
|
67 587
|
77 170
|
103 996
|
147 709
|
216 914
|
254 993
|
|
| Additional Paid In Capital |
1 050
|
1 296
|
1 296
|
11 702
|
11 837
|
18 008
|
17 973
|
57 103
|
58 960
|
57 349
|
64 916
|
64 916
|
64 916
|
64 916
|
64 916
|
108 385
|
153 100
|
185 190
|
216 611
|
243 684
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
25
|
0
|
0
|
0
|
412
|
282
|
461
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
297
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19
|
34
|
0
|
0
|
0
|
60
|
148
|
198
|
0
|
322
|
0
|
473
|
422
|
|
| Total Equity |
1 866
N/A
|
3 092
+66%
|
10 876
+252%
|
24 360
+124%
|
19 112
-22%
|
21 447
+12%
|
8 136
-62%
|
44 468
+447%
|
40 094
-10%
|
27 851
-31%
|
35 389
+27%
|
33 898
-4%
|
24 654
-27%
|
22 742
-8%
|
16 100
-29%
|
68 446
+325%
|
108 997
+59%
|
107 803
-1%
|
85 120
-21%
|
105 838
+24%
|
|
| Total Liabilities & Equity |
2 541
N/A
|
6 749
+166%
|
19 837
+194%
|
30 172
+52%
|
24 726
-18%
|
40 681
+65%
|
41 201
+1%
|
86 689
+110%
|
140 220
+62%
|
67 758
-52%
|
78 904
+16%
|
53 537
-32%
|
48 707
-9%
|
41 960
-14%
|
36 405
-13%
|
100 652
+176%
|
164 654
+64%
|
248 159
+51%
|
194 471
-22%
|
187 074
-4%
|
|
| Shares Outstanding | |||||||||||||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
2
|
3
|
3
|
3
|
7
|
7
|
8
|
8
|
8
|
8
|
8
|
8
|
16
|
25
|
30
|
36
|
49
|
|
Switch to:
Switch to:
See Also
Discover More
